Yıl: 2005 Cilt: 36 Sayı: 3 Sayfa Aralığı: 109 - 115 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi

Öz:
Bu çalışmada amaç, uteroplasental değişikliklerle ilişkili olduğu düşünülen endotelyal nitrik oksit sentetaz düzeylerinin (eNOS) preeklamptik ve kontrol gebelere ait fetal ve maternal yüz plasentalarında immünohistokimyasal olarak incelenmesidir. Çalışmada, 10 preeklamptik ve 5 normal kontrol grubu gebeye ait plasenta örnekleri ve kan değerleri incelendi. Son trimestir gebeliklerde proteinüri varlığı ve kan basıncı (>140/90 mm/Hg) değerlerine göre preeklampsi ve kontrol grupları belirlendi. Preeklamptik ve normal plasenta doku örneklerinin maternal ve fetal yüzlerine ait parafin bloklar hazırlandı. Alınan kesitler Hemotoksilen- Eosin ile boyandı ve ışık mikroskobunda histopatolojik değişiklikler değerlendirildi. Plasental doku örneklerinde eNOS aktivasyonu streptavidin- biotin immünohistokimyasal yöntemi uygulanarak incelendi. Preeklamptik tanı kriterleri olan sistolik-diastolik kan basıncı ve idrarda protein değerlerinin kontrol grubu değerlerine göre istatistiksel olarak anlamlı derecede yüksek olduğu bulundu. Preeklamptik grup plasentalarında, spiral arterler ve desiduaya ait histopatolojik değişiklikleri yansıtan ışık mikroskobik bulgular saptandı. İmmünohistokimyasal inceleme sonucunda eNOS immünlokalizasyonu villusların sinsisyotrofoblastik hücrelerinde gözlendi. İmmünohistokimyasal sonuçlar skorlama yöntemi kullanılarak değerlendirildi. Kontrol ve preeklamptik grupların fetal ve maternal plasenta doku örneklerine ait immunohistokimyasal skor değerleri arasında bir fark izlenmedi (p>0.05). Preeklamptik grup maternal plasenta örneklerine ait immunohistokimyasal skor ortalaması kontrol grubuna göre istatistiksel olarak anlamlı düzeyde artmış bulundu (p<0.005). Aynı grubun fetal plasenta örneklerinde de kontrol grubuna göre artış bulundu ancak istatistiksel anlamlılık saptanmadı (p>0.05). Sinsisyotrofoblast hücrelerindeki eNOS aktivasyon artışının, fetoplasental dolaşımdaki hemodinamik değişikliklerle olaylanan preeklampside rol oynadığı sonucuna varılmıştır.
Anahtar Kelime: Nitrik oksit sentaz Preeklampsi Endotel Plasenta İmmünohistokimya

Konular: Kadın Hastalıkları ve Doğum Genel ve Dahili Tıp Biyofizik

Evaluation of endothelial nitric oxide synthase (eNOS) immunreactivity of fetal and maternal placenta

Öz:
Background and Design.- This study aims to determine the endothelial nitric oxide synthase (eNOS) immunreactivity of fetal and maternal placentas in preeclamptic and normal individuals and to investigate the possible relationship with the uteroplacental changes in preeclampsia. Material and Methods.- In this study, placental and blood samples of 10 preeclamptic group and control group were determined according to values of blood pressure (>140/90mmHg) and presence of proteinuria in the last trimester of pregnancy. Paraffin blocks of maternal and fetal sides of preeclamptic and normal placental tissue samples were prepared. Sections stained with Hematoxylin-Eosin and histopathology changing was evaluated by light microscope. eNOS activation were examined in samples of placenta tissues by streptavidine-biotine immunohistochemical methods. Results.- Systolic and diastolic blood pressure and proteinuria, which are diagnostic criteria of preeclampsia, were found increase and statistically significant in preeclamptic group comparing with the control group. Spiral arterioles and decidual histopathologic changes in the placentas of preeclamptic group were observed on light microscope. eNOS immunlocalization was observed in the villous of syncytiotrophoblastic cells by immunohistochemical examination. Immunohistochemical results were evaluated by scoring system. There was no significant difference between immunohistochemical score values of fetal and maternal tissue samples of two groups. Mean immunohistochemical score (IHS) values of maternal tissue samples in preeclamptic group were significantly higher than the control group values (p>0.05), when fetal tissue samples were considered, score values of preeclamptic group were also higher than the control group (p>0.005), but it was not statistically significant (p>0.05). Conclusion.- In conclusion, increase of eNOS activity in syncytiotrophoblastic cells play a role in preeclampsia related with hemo-dynamic changes in fetoplacental circulation.
Anahtar Kelime: Endothelium Placenta Immunohistochemistry Nitric Oxide Synthase Pre-Eclampsia

Konular: Kadın Hastalıkları ve Doğum Genel ve Dahili Tıp Biyofizik
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Lavery JP. The Human Placenta Clinical Perspectives. Maryland, Asben Publication, 1987; 25.
  • 2. Merviel P, Carbillon L, Challier JC, Rabreau M, Beaufils M and Uzan S. Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol 2004; 115: 134.
  • 3. Beksaç MS, Demir N, Koç A, Yüksel A. Obstetrik; maternal-fetal tıp ve perinatoloji. Medical Network Ankara, 2001; 625-645.
  • 4. Brosens I, Robertson WB, Dixon HG: The physiological response of vessels of the placental bed to normal pregnancy. J Path Bact 1967; 93: 569-579.
  • 5. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small for gestation age infants. Br J Obstet Gynecol 1986; 93: 1049-1059.
  • 6. Thiemmermann C. The role of the L-arginine-nitric oxide pathway in circulatory shock. Adv Pharmacol 1994; 28: 45-79.
  • 7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
  • 8. Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in human fetal-placental circulation. Am J Obstet Gynecol 1992; 166: 224-230.
  • 9. Zarlingo TJ, Eis AL, Brockman DE, Kossenjans W, Myatt L. Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta 1997; 18: 511-520.
  • 10. Lee CN, Chang SW, Cho NH, Cho SH. Nitrous oxide synthase expression in placenta of preeclampsia. J Korean Med Sci 1997; 12: 532-538.
  • 11. Matsubara S, Takizawa T, Takayama T, Izumi A, Watanabe T, Sato I. Immunoelectron microscopic localization of endothelial nitric oxide synthase in human placental terminal villous trophoblasts-normal and preeclamptic pregnancy. Placenta 2001; 22: 782-786.
  • 12. Zeeman GG and Dekker GA. Pathogenesis of preeclampsia: a hypothesis. Clin Obstet and Gynecol 1992; 35: 317-337.
  • 13. Sağol S, Özkınay E, Özşener S. Impaired antioxidant activity in women with pre-eclampsia. Int J Gynecol Obstet 1999; 64: 121-127.
  • 14. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, Van Assche A. Placental bed spiral arteries in the hypertensive disordes of pregnancy. Br J Obstet Gynecol 1991; 98: 648-655.
  • 15. Pinto A, Sorrentino R, Sorrentino T, Miranda L, Biondi A, Martinelli P. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and in its impeirment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 164: 507-513.
  • 16. Brennecke SP, Gude NM, Diliulio JL, King RG. Nitric oxide synthase activity in human placental villous tissue is reduced in pre-eclampsia. Hypertens Preg 1994; 13: 306-310.
  • 17. Zöllner S, Haseloff RF, Kirilyuk IA, Blasig IE, Rubanyi GM. Nitroxides increase the detectable amount of nitric oxide released from endothelial cells. J Biol Chem 1997; 272: 23076-23080.
  • 18. Norman JE, Cameron IC. Nitric oxide in human uterus. Rev Reprod 1996; 1: 61-68.
  • 19. Myatt L, Brockman DE, Eis ALW, Pollock JS. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 1993; 14: 487-495.
  • 20. Eis ALW, Brockman DE, Pollock JS, Myatt L. Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta 1995; 16: 113-126.
  • 21. Buttery LDK, McCarthy A, Springall DR, Sullivan MH, Elder MG, Michel T, Polak JM. Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994; 15: 257-265.
  • 22. Myatt L, Eis AL, Brockman DE, Greer IA, Lyall F. Endothelial noxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod 1997; 12: 167-172.
  • 23. Conrad KP, Vill M, McGuire PG, Dail WG, Davis AK: Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. Faseb J 1993; 7: 1269-1276.
  • 24. Conrad KP and Davis AK. Nitric oxide synthase activity in placentae from women with pre-eclampsia. Placenta 1995; 16: 691-699.
  • 25. Ranta V, Viinikka L, Halmesmäki E, Ylikorkala O. Nitric oxide production with preeclampsia .Obstet Gynecol 1999; 93: 442-445.
  • 26. Pitchard JA, Pitchard SA. Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 1975; 123: 543-552.
  • 27. Sweiry JH, Page KR, Dacke CG, Abramovich DR, and Yudilevich DL. Evidence of saturable uptake mechanisms at maternal and fetal sides of the perfused human placenta by rapid paired-tracer dilution: studies with calcium and choline. J Dev Physiol 1986; 6: 435-445.
APA MUTLU C, KOYUTURK M, KARPUZ V (2005). Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. , 109 - 115.
Chicago MUTLU Canan,KOYUTURK Meral,KARPUZ Vildan Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. (2005): 109 - 115.
MLA MUTLU Canan,KOYUTURK Meral,KARPUZ Vildan Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. , 2005, ss.109 - 115.
AMA MUTLU C,KOYUTURK M,KARPUZ V Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. . 2005; 109 - 115.
Vancouver MUTLU C,KOYUTURK M,KARPUZ V Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. . 2005; 109 - 115.
IEEE MUTLU C,KOYUTURK M,KARPUZ V "Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi." , ss.109 - 115, 2005.
ISNAD MUTLU, Canan vd. "Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi". (2005), 109-115.
APA MUTLU C, KOYUTURK M, KARPUZ V (2005). Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. Cerrahpaşa Tıp Dergisi, 36(3), 109 - 115.
Chicago MUTLU Canan,KOYUTURK Meral,KARPUZ Vildan Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. Cerrahpaşa Tıp Dergisi 36, no.3 (2005): 109 - 115.
MLA MUTLU Canan,KOYUTURK Meral,KARPUZ Vildan Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. Cerrahpaşa Tıp Dergisi, vol.36, no.3, 2005, ss.109 - 115.
AMA MUTLU C,KOYUTURK M,KARPUZ V Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. Cerrahpaşa Tıp Dergisi. 2005; 36(3): 109 - 115.
Vancouver MUTLU C,KOYUTURK M,KARPUZ V Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi. Cerrahpaşa Tıp Dergisi. 2005; 36(3): 109 - 115.
IEEE MUTLU C,KOYUTURK M,KARPUZ V "Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi." Cerrahpaşa Tıp Dergisi, 36, ss.109 - 115, 2005.
ISNAD MUTLU, Canan vd. "Preeklamptik ve normal plasentada endotelyal nitrik oksit sentetaz immünreaktivitesinin incelenmesi". Cerrahpaşa Tıp Dergisi 36/3 (2005), 109-115.